Aristides Capital’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-100,000
Closed -$154K 173
2022
Q1
$154K Buy
+100,000
New +$154K 0.09% 152